學術發表

仔細評估、反覆驗證
將創意從發想到落實

期刊類

A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases.

PublishedEur J Immunol. 2005 Jul;35(7):2239-49.
Author (s)Huang CC, Lu YF, Wen SN, Hsieh WC, Lin YC, Liu MR, Chiang E, Chang CN, Lin RH.
more

Cross-linking of P-selectin glycoprotein ligand-1 induces death of activated T cells.

PublishedBlood. 2004 Nov 15;104(10):3233-42. Epub 2004 Jun 15.
Author (s)Chen SC, Huang CC, Chien CL, Jeng CJ, Su HT, Chiang E, Liu MR, Wu CH, Chang CN, Lin RH.
more

研討會

Checkpoint Regulator, Neihulizumab, as a Novel Therapy for Immunological Diseases

PublishedB & T Cell-Mediated Autoimmune Disease Drug Development
Author (s)Judy Chou
more

Efficacy and Safety of Neihulizumab (AbGn-168H) in Patients with Active Psoriatic Arthritis: 24-week Results from a Phase II Open Label Study

PublishedAmerican College of Rheumatology (ACR)
Author (s)Stanley B. Cohen, Justus J. Fiechtner, Philip J. Mease, Jeffrey L. Kaine, Arthur Kavanaugh, Yi-Lin (Irene) Cheng, Claire Chou, Ting-Ying Cheng, I-Ming Cho, Shih-Yao Lin and Mark C. Genovese
more

NEIHULIZUMAB (ABGN-168H) IN PATIENTS WITH STEROID-REFRACTORY ACUTE GRAFTVERSUS- HOST-DISEASE (SR-AGVHD): PRELIMINARY RESULTS OF A PHASE I STUDY

PublishedEuropean Hematology Association (EHA)
Author (s)Sameen Abedin, Mehdi Hamadani, Shernan G Holtan, Sarah Anand, Irene Cheng, Iming Cho, Ting-Ying Cheng, Shih-Yao Lin and Paul J Martin
more

Phase II open label, single arm, multiple dose study of Neihulizumab , an anti CD162 (PSGL 1) antibody, in patients with moderate to severe active, anti TNFα and/or anti integrin refractory ulcerative colitis

PublishedDigestive Disease Week (DDW)
Author (s)David T. Rubin , Scott Lee , Lucky Flores , Gustavo Albizu Angulo , Ellen Scherl , Surinder Saini , Shipra Patel , Yi Lin (Irene) Cheng , Ting Ying (Hazel) Cheng , and Shih Yao Lin
more

Phase Ia,first-in-human study of AbGn-107,a novel antibody-drug conjugate(ADC),in patients with gastric,colorectal,pancreatic,or biliary cancers

PublishedAmerican Society of Clinical Oncology (ASCO)
Author (s)Andrew H.Ko,Andrew L.Coveler,Benjamin L.Schlechter,Tanios S.Bekaii-Saab,Brian M.Wolpin,Jeffery W.Clark,Bruno Bockorny,Yi-Lin Cheng,Ting-Ying Cheng,Peter Langecker and Shih-Yao Lin
more